Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Off-hours Primary PCI Still Have the Highest Mortality Rate?

According to this contemporary study, in the current organized STEMI network, patients admitted to a tertiary high-volume center for primary PCI are managed similarly and have similar prognosis regardless admission time. 

¿Las angioplastias primarias a la madrugada siguen teniendo mayor mortalidad?

Several prior studies have shown primary PCI during off-hours (6 pm to 8 am) had worse outcomes vs. on-hour interventions (8 am to 6 pm). Something similar occurred when comparing weekend and holiday outcomes vs. working days. 

This study analyzed the outcomes of 2167 consecutive STEMI patients admitted to a tertiary primary PCI center 24 hours, 7 days a week, all year round.


Read also: Net Benefit of Left Atrial Appendage Closure vs. Anticoagulation in Atrial Fibrillation.


1048 patients (48.3%) were admitted on-hours and 1119 (51.7%) off-hours.

Baseline clinical characteristics were well balanced between the groups, including cardiac arrest rate (7.9% vs 8.8%) and cardiogenic shock (12.3% vs 14.7%).

Mean time between symptom onset and fist medical contact and mean time between first contact and sheath insertion resulted similar between both groups (120 min vs. 126 min; p=0.25 y 90 min vs. 93 min; p=0.58, respectively), same as radial access rate (85.6% vs. 87.5%; p=0.27).


Read also: International Consensus to Prevent Radial Artery Occlusion After Interventions.


There was no association between time and procedure and in-hospital mortality (8.1% vs. 7.0%; p=0.49) and mortality at one year (11.0% vs. 11.1%; p=0.89).

Conclusion

The contemporary organized STEMI network has successfully beaten the myth of worse off hours PCI prognosis. This was true for both in-hospital mortality and one year mortality, at least for one high volume tertiary center. 

Original title: On- Versus Off-Hours Presentation and Mortality of ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention.

Reference: Benoit Lattuca et al. J Am Coll Cardiol Intv 2019, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...